Covered recipient · General Payments record
FADI HADDAD
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2022–2024
$1,828.86
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $342.17 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $112.28 | 1 |
| ABBVIE INC. | $77.34 | 1 |
| Astellas Pharma US Inc | $50.00 | 2 |
| Incyte Corporation | $48.16 | 1 |
| Celgene Corporation | $27.79 | 1 |
| Lilly USA, LLC | $26.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $77.34 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103859327 | CMS |
| Astellas Pharma US Inc | $22.09 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139295004 | CMS |
| Astellas Pharma US Inc | $27.91 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139409109 | CMS |
| Celgene Corporation | $27.79 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101128472 | CMS |
| Incyte Corporation | $48.16 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141171175 | CMS |
| Lilly USA, LLC | $26.60 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134975144 | CMS |
| Novartis Pharmaceuticals Corporation | $112.28 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086954959 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.